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Purpose: To demonstrate eco-friendly biosynthesis of gold nanoparticles by Enterobacteriaceae.  
Methods: Pure colonies of nine different bacteria from the Enterobacteriaceae family were separated 
from water and cultured in Luria Bertani broth medium. Their respective supernatants were examined for 
ability to produce gold nanoparticles. In this step, 1 mM solution of Gold(III) chloride trihydrate H(AuCl4) 
added to reaction matrices (supernatant) separately. The reaction was performed in a dark environment 
at 37 ºC. After 24 h, it was observed that the color of the solutions turned to dark purple from light 
yellow. The gold nanoparticles were characterized by UV-Visible spectroscopy, dynamic light scattering, 
scanning electron microscopy and Fourier transform infrared spectroscopy (FTIR) for yield, particle size, 
shape and presence of different functional groups, respectively. The nanoparticles were centrifuged and 
re-dispersed in double distilled water thrice to purify them for FTIR studies. 
Results: The gold nanoparticles were fairly uniform in size, spherical in shape and with Z-average 
diameter ranging from 11.8 to 459 nm depending on the bacteria used. FTIR spectra revealed the 
presence of various functional groups in the gold nanoparticles which were also present in the bacterial 
extract.  
Conclusion: The current approach suggests that rapid synthesis of nanoparticles would be feasible in 
developing a biological process for mass scale production of gold nanoparticles. 
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INTRODUCTION 
 
Gold is a rare element which has been used 
to treat different diseases such as cancer 
diagnostics and therapy. The specifications of 
gold nanoparticles differ from bulk gold in 
size and shape [1-2]. Gold nanoparticles 
have been used as anti-HIV, anti-
angiogenesis, anti-malarial and anti-arthritic 
agent [2-4], Furthermore, gold nanoparticles 
are used for delivering molecules into cells to 
slow down cancer cell growth and/or destroy 
cancer cells [5]. They play a major role in the 
treatment of cancer due to its biocompatibility 
and strong interaction with soft bases such as 
thiols [6].   
 
Metallic nanoparticles can be synthesized 
through different methods such as spark 
discharging, electrochemical reduction, 
solution irradiation and cryochemical 
synthesis [7]. Although chemical reduction is 
the most applied method for the preparation 
of metallic nanoparticles, biological or green 
methods of nanoparticles synthesis would be 
preferable due to its eco-friendly properties. 
Furthermore, green synthesis of metallic 
nanoparticles offer better manipulation, 
stabilization and control over crystal growth 
due to slower kinetics [8].  
Biological methods for the synthesis of 
nanoparticles include the use of biological 
agents such as bacteria, fungi, 
actinomycetes, yeast and plants [9,10]. 
Biological agents secrete a great deal of 
enzymes that bring about enzymatic 
reduction of metallic ions. The enzyme, 
nitrate reductase, has been found to be 
responsible for the synthesis of nanoparticles 
in fungi [11-12].  
 
The supernatant used for the synthesis of 
nanoparticles is simpler to handle and the 
downstream processing of the supernatant is 
much simpler. The synthesizing process is 
low-cost and non-toxic [13,14]. The objective 
of this study is to demonstrate the feasibility 
of a bacterial/enzyme-based in vitro approach 
for the biosynthesis of gold nanoparticles 
from Enterobacteriaceae family. 
EXPERIMENTAL  
 
Materials   
 
Gold (III) chloride trihydrate (AuCl4), eosin 
methylene blue (EMB) agar, Luria Bertani 
broth medium and other chemical reagents 
were purchased from Merck Germany. Pure 
colonies of different bacteria from the 
Enterobacteriaceae family were separated 
from city water and waste water by multipe 
tube fermentation technique. The genus of 
bacteria were approved by Department of 
Biotechnology, Mazandaran University of 
Medical Sciences, School of Pharmacy, Sari, 
Iran. 
 
Biosynthesis of gold nanoparticles  
 
Each bacterium (see Table 1) was cultured in 
EMB agar for 48 h at 37 °C ,and then the 
colonies were transferred to Luria Bertani 
broth medium and incubated-centrifuged at 
37 °C and 150 rpm for 72 h. The cultures 
were centrifuged at 6,000 rpm for 20 min and 
the supernatants used for the synthesis of 
gold nanoparticles. In this procedure, one set 
of 1 mM solution of AuCl4 was prepared by 
dissolving 0.0232 g of the salt in 100 mL of 
double distilled water. The solution (100 ml) 
of the solution was added separately to 100 
ml of the supernatant for each bacterium and 
incubated again for 24 h at 37 °C in a dark 
place. The color of the preparation changed 
to dark purple, indicating the formation of 
gold nanoparticles in the solution. Finally, the 
gold nanosuspensions were stored carefully 
in dark vials pending further analysis.  
 
Characterization of nanoparticles 
 
The reduction of AuCl4 to gold nanoparticles 
was confirmed by ultraviolet (UV) 
spectroscopy, scanning from 400 to 700 nm 
(Genesys 2 spectrophotometer, USA). 
Dynamic light scattering (DLS) is a non-
invasive technique to measure the size and 
size distribution of nanoparticles dispersed in 
a liquid. Evaluation of size and polydispersity 
of the particles was carried out using a 
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Zetasizer analyzer (Zetasizer 3600) at 25 °C 
with a scattering angle of 90° (Malvern 
Instruments, UK). The surface and shape 
characteristics of the gold nanoparticles were 
determined by scanning electron microscopy 
(model 2360, Leo Oxford England) while 
FTIR analysis was carried out to identify 
different functional groups. A blend of the 
extract and potassium bromide (KBr) in 1:100 
ratio was compressed to a 2 mm semi-
transparent disk. FTIR spectra over the 
wavelength range of 4000 – 400 cm-1 were 
recorded using an FTIR spectrometer (Perkin 
Elmer, Germany). The gold nanoparticles 
were centrifuged and re-dispersed in double 





Addition of Enterobacteriaceae family‘s 
biomass (Table 1) to 1 mM aqueous H(AuCl4) 
solution led to the development of a dark 
purple solution after 24 h of reaction, 
indicating the formation of gold nanoparticles 
as shown in the UV/Vis absorption spectrum 
in Fig 1.   
 
Ultraviolet (UV) spectroscopy confirmed the 
reduction of AuCl4 to gold nanoparticles that 
can be identified from the peaks obtained 
around 650 nm, which is the signature for the 
gold nanoparticle formation, apart from the 
color change. The shift in the position of the 
peak can be seen for gold nanoparticles 
synthesized in different media [15].  
 
The size of gold nanoparticles produced by 
various Enterobacteriaceae genera is 
presented in Table 1 while Fig 2 shows the 
size distribution of two of the nanoparticle 
batches. Size distribution was bimodal (Fig 
2A) for some nanoparticle batches and 
unimodal for others (Fig 2B, and Table 1).  
 
SEM results illustrate that the gold 
nanoparticles were spherical in shape and in 
the size range, 20 to 400 nm (Fig 3). Some 
micrographs show that the some of the 
nanoparticles occurred singly (Fig 4A) while  
 
Table 1: Size of gold nanoparticles and FTIR 
peaks of nine different genera of 
Enterobacteriaceae family 
 




peaks from  
1400-1700 
cm-1 
Escherichia coli           11.8, 130 1404-  
1453-  
1652 
Citrobacter freundii 321 1403-  
1452-  
1641 
Citrobacter koseri                  32, 127 1403-  
1450-  
1659 





18.3 1406-  
1455-  
1651 












Klebsiella oxytoca 110 1431-  
1450-  
1657 
 *Where two values (bimodal distribution) are indicated, 





Fig 1: UV/Vis spectrum of gold nanoparticles 
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Fig 2: Size distribution patterns of gold 
nanoparticles generated from Enterobacteriaceae; 
A = bimodal distribution; B = unimodal distribution 
 
   
 
Fig 3: SEM images of gold nanoparticles 
produced by Enterobacteriaceae family, showing 




Fig 4: Typical FTIR spectrum of gold nanoparticles 
generated by Enterobacteriaceae 
 
others were aggregated (Fig 4B). 
Aggregation may be the cause of bimodal 
distribution of the nanoparticales.   
 
A representative FTIR spectrum of the gold 
nanoparticles is shown in Fig 4 while the 
wave numbers of the major peaks are shown 
in Table 1.  The spectrum represents the 
various functional groups, such as amide, 





Biological methods used for the synthesis of 
nanoparticles include both extracellular and 
intracellular methods [11]. The exact 
mechanism for the synthesis of nanoparticles 
using biological agents has not yet been 
elucidated but it has been suggested that 
various biomolecules are responsible for the 
synthesis of nanoparticles. It seems that the 
cell wall of microorganisms play a major role 
in the intracellular synthesis of nanoparticles. 
Mukherjee et al postulated that the 
mechanism of synthesis of nanoparticles 
occurs in 3 stages: trapping, bioreduction and 
synthesis. The authors explained that the 
fungal cell surface interacts electrostatically 
with metal ions and traps them in the 
process. Thereafter, the enzymes present in 
the cell wall bioreduce the metal ions and 
finally, synthesis of nanoparticles takes place 
as a consequence of particle aggregation 
[11].  
 
The mechanism of extracellular biosynthesis 
of nanoparticles is proposed as a nitrate 
reductase-mediated synthesis that secretes 
the enzyme, nitrate reductase, which then 
brings about bioreduction of metal ions and 
synthesis of nanoparticles [14]. The FTIR 
spectrum of the nanoparticles indicates the 
presence of various chemical groups, one of 
which is an amide. The presence also of –
COO–, possibly due to amino acid residues 
may indicate that protein co-exists with the 
gold nanoparticles. An amide I band was 
observed at 1630 to 1650 cm-1. This is further 
confirmed by the band at 3406 - 3412 cm-1. 
A B 
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The band at 1626 cm-1 corresponds to amide 
I due to carbonyl stretch in proteins. It seems 
that the FTIR spectrum shows the presence 
of functional groups, such as amide linkages 
and –COO–, possibly between amino acid 





The biological process for the formation of 
gold nanoparticles using Enterobacteriaceae 
family has been demonstrated. This method 
is likely to be less costly, simpler, and require 
less energy and raw materials than existing 
chemical methods. The development of an 
eco-friendly process for the synthesis of 
metallic nanoparticles constitutes an 




This work was financially supported by 





1. Sperling RA, Gil PR,  Zhang F,  Zanella M, Parak 
WJ. Biological applications of gold 
nanoparticles. Chem. Soc. Rev. 2008; 37: 
1896-1908. 
2. Boisselier E, Astruc D. Gold nanoparticles in 
nanomedicine: preparations, imaging, 
diagnostics, therapies and toxicity. Chem. Soc. 
Rev, 2009; 38: 1759-1782. 
3. Reddy VR. Gold nanoparticles: synthesis and 
applications. Synlett 2006; 11: 1791–1792. 
4. Mukherjee P, Bhattacharya R, Wang P, Wang L, 
Basu S, Nagy JA, Atala A, Mukhopadhyay D, 
Soker S. Antiangiogenic properties of gold 
nanoparticles. Clin. Cancer Res. 2005; 11:  
3530–3534.  
5. Navarro M, Pérez H, Sلnchez-Delgado R.A. 
Toward a novel metal-based chemotherapy 
against tropical diseases. 3. Synthesis and 
antimalarial activity in vitro and in vivo of the 
new gold-chloroquine complex 
[Au(PPh3)(CQ)]PF6. J. Med. Chem. 1997; 40: 
1937–1939.  
6. Tsai CY, Shiau AL, Chen SY, Chen YH, Cheng PC, 
Chang MY, Chen DH, Chou CH, Wang CR, 
Wu CL Amelioration of collagen-induced 
arthritis in rats by nanogold. Arthritis Rheum. 
2007; 56: 544–554.  
7. Ali Syed M, Habib Ali Bokhari S. Gold nanoparticle-
based microbial detection and identification. J. 
Biomed. Nanotech. 2011; 7: 229-237. 
8. Nam J, Won N, Jin H, Chung H, Kim S. pH-induced 
aggregation of gold nanoparticles for 
photothermal cancer therapy. J. Am. Chem. 
Soc. 2009; 131: 13639–13645. 
9. Bhattacharya R, Mukherjee P. Biological properties 
of naked nanoparticles. Adv. Drug Deliv. Rev. 
2008; 60: 1289–1306. 
10. Vaidyanathan R, Kalishwaralal K, Gopalram S, 
Gurunathan S. Nanosilver - The burgeoning 
therapeutic molecule and its green synthesis. 
Biotech. Adv. 2008; 27: 924–937. 
11. Mukherjee P, Ahmad A, Mandal D, Senapati S, 
Sainkar SR, Khan MI, Ramani R, Parischa R, 
Kumar PAV, Alam M, Sastry M, Kumar R. 
Bioreduction of AuCl4- ions by the fungus, 
Verticillium sp. and surface trapping of the gold 
nanoparticles formed. Angew. Chem. Int. Ed. 
2001; 40: 3585–3588. 
12. Vigneshwaran N, Ashtaputre NM, Varadarajan PV, 
Nachane  RP, Paralikar KM, Balasubramanya 
RH. Biological synthesis of silver nanoparticles 
using the fungus Aspergillus flavus. Mat. Lett. 
2007; 61: 1413–1418. 
13. Reddy AS, Chen CY, Chen CC, Jean JS, Chen HR, 
Tseng MJ, Fan CW, Wang JC. Biological 
synthesis of gold and silver nanoparticles 
mediated by the bacteria Bacillus subtilis. J. 
Nanosci. Nanotechnol. 2010; 10: 6567-6574.  
14. Kumar SA, Ayoobul AA, Absar A, Khan MI. 
Extracellular bv biosynthesis of CdSe quantum 
dots by the fungus, Fusarium Oxysporum. J. 
Biomed. Nanotechnol. 2007; 3: 190–194. 
15. Li JJ, Chen Y, Wang AQ, Zhu J, Zhao JW. Hesse 
M, Meier H, Zeeh B. Effect of gold 
nanoparticles on the fluorescence excitation 
spectrum of α-fetoprotein: local environment 
dependent fluorescence quenching. 
Spectrochim Acta 2011; 78: 243-247.  
 
  
